Portola Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Portola Pharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $9.48 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2020-03-31 was $9.48M, a 47.02% decline year-over-year.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2019-12-31 was $10.88M, a 47.73% decline year-over-year.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2019-09-30 was $11.05M, a 3.05% decline year-over-year.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2019-06-30 was $12.25M, a 7.27% decline year-over-year.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2019 was $52.08M, a 7.68% decline from fiscal 2018.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2018 was $56.41M, a 30.32% increase from fiscal 2017.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2017 was $43.28M, a 42.56% increase from fiscal 2016.
- Portola Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2016 was $30.36M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2020-03-31 | $9.48M 10-Q · filed 2020-05-11 | $20.36M derived: sum of 2 quarters · filed 2020-05-11 | $31.41M derived: sum of 3 quarters · filed 2020-05-11 | $43.66M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-12-31 | $10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $21.93M derived: sum of 2 quarters · filed 2020-02-28 | $34.18M derived: sum of 3 quarters · filed 2020-02-28 | $52.08M 10-K · filed 2020-02-28 | |
| 2019-09-30 | $11.05M 10-Q · filed 2019-11-05 | $23.30M derived: sum of 2 quarters · filed 2019-11-05 | $41.19M 10-Q · filed 2019-11-05 | $62.01M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-06-30 | $12.25M 10-Q · filed 2019-08-07 | $30.15M 10-Q · filed 2019-08-07 | $50.97M derived: sum of 3 quarters · filed 2020-05-11 | $62.36M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-03-31 | $17.89M 10-Q · filed 2020-05-11 | $38.71M derived: sum of 2 quarters · filed 2020-05-11 | $50.11M derived: sum of 3 quarters · filed 2020-05-11 | $63.32M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $20.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $32.21M derived: sum of 2 quarters · filed 2020-02-28 | $45.43M derived: sum of 3 quarters · filed 2020-02-28 | $56.41M 10-K · filed 2020-02-28 | $55.36M 10-K · filed 2019-03-01 |
| 2018-09-30 | $11.39M 10-Q · filed 2019-11-05 | $24.61M derived: sum of 2 quarters · filed 2019-11-05 | $35.59M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $13.21M 10-Q · filed 2019-08-07 | $24.19M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $10.98M 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | $43.28M 10-K · filed 2020-02-28 | ||||
| 2016-12-31 | $30.36M 10-K · filed 2019-03-01 | ||||
| 2014-09-30 | $2.15M 10-Q · filed 2014-11-10 | $4.57M derived: sum of 2 quarters · filed 2014-11-10 | $6.88M 10-Q · filed 2014-11-10 | $8.39M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2014-06-30 | $2.42M 10-Q · filed 2014-08-06 | $4.73M 10-Q · filed 2014-08-06 | $6.24M derived: sum of 3 quarters · filed 2014-08-06 | $7.78M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2014-03-31 | $2.30M 10-Q · filed 2014-05-13 | $3.82M derived: sum of 2 quarters · filed 2014-05-13 | $5.35M derived: sum of 3 quarters · filed 2014-11-10 | $6.56M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $3.05M derived: sum of 2 quarters · filed 2014-11-10 | $4.26M derived: sum of 3 quarters · filed 2014-11-10 | $4.97M 10-K · filed 2014-03-03 | |
| 2013-09-30 | $1.53M 10-Q · filed 2014-11-10 | $2.74M derived: sum of 2 quarters · filed 2014-11-10 | $3.46M 10-Q · filed 2014-11-10 | $4.20M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $1.21M 10-Q · filed 2014-08-06 | $1.92M 10-Q · filed 2014-08-06 | $2.67M derived: sum of 3 quarters · filed 2014-08-06 | $3.32M derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-03-31 | $713.00K 10-Q · filed 2014-05-13 | $1.46M derived: sum of 2 quarters · filed 2014-05-13 | $2.11M derived: sum of 3 quarters · filed 2014-05-13 | $2.78M derived: sum of 4 quarters · filed 2014-05-13 | |
| 2012-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.40M derived: sum of 2 quarters · filed 2014-03-03 | $2.07M derived: sum of 3 quarters · filed 2014-03-03 | $2.81M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $656.00K 10-Q · filed 2013-11-06 | $1.32M derived: sum of 2 quarters · filed 2013-11-06 | $2.07M 10-Q · filed 2013-11-06 | ||
| 2012-06-30 | $668.00K 10-Q · filed 2013-08-14 | $1.41M 10-Q · filed 2013-08-14 | |||
| 2011-12-31 | $2.35M 10-K · filed 2014-03-03 |